Results 201 to 210 of about 72,904 (298)

VV‐ECMO Combined With M‐TEER for the Treatment of Mitral Valve Papillary Muscle Rupture Following Acute Myocardial Infarction PCI: A Case Report

Clinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Mitral valve papillary muscle rupture represents a rare yet critical complication of acute myocardial infarction, often leading to severe mitral regurgitation and subsequent pulmonary edema with high mortality. Despite optimal ventilatory support and pharmacological management, patients often exhibit refractory hypoxemia, rendering surgical ...
Zhenjiang Liu
wiley   +1 more source

Transcatheter aortic valve replacement or surgical aortic valve replacement: Establishing a middle ground. [PDF]

World J Cardiol
Bhogal S, Bhandari T, Batta A, Mohan B.
europepmc   +1 more source

Burden of Liver Disease Among Individuals With Turner Syndrome and Klinefelter Syndrome: A Comprehensive Perspective

Chronic Diseases and Translational Medicine, Volume 12, Issue 1, Page 39-48, March 2026.
ABSTRACT The liver is increasingly recognized as a major regulator of systemic cardio‐renal‐metabolic health. Evidence is mounting that sex‐chromosome dosage per se itself, independent of gonadal sex hormones, modulates hepatic physiology and liver disease risk.
Mohamad Jamalinia, Amedeo Lonardo, Ralf Weiskirchen   +2 more
wiley   +1 more source

Intramyocardial Dissection and Sinus of Valsalva Aneurysm Complicating Surgical Aortic Valve Replacement. [PDF]

JACC Case Rep
Bouziane M, Haboub M.
europepmc   +1 more source

Aortic flow hemodynamics after surgical aortic valve replacement: comparison with a healthy subject [PDF]

, 2016
Athanasiou, T, Cheng, Z, Jarral, OA, O’Regan, DP, Pirola, S, Xu, X   +5 more
core  

Efficacy of SGLT2 Inhibitors on Clinical Outcomes After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta‐Analysis

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 2, March 2026.
SGLT2 inhibitor therapy was associated with a significantly lower risk of the composite outcome of all‐cause mortality or heart failure hospitalization at one year, as well as each component individually. ABSTRACT Background Sodium‐glucose cotransporter 2 (SGLT2) inhibitors improve cardiovascular (CV) outcomes in patients with heart failure (HF) and ...
Shaikh Muhammad Daniyal, Naveen Murad Khatoon, Anas Rasool, Isbah Gul, Sabula Tabish, Shireen Asifa, Ayan Khalid, Zunaira Aftab, Muhammad Burhan, Syeda Laiba Fahim, Habiba Tauqir Gondal, Muhammad Asfandyar Nadir, Syed Zaeem Ahmed, Danish Ali Ashraf, Somaiya Ahmed   +14 more
wiley   +1 more source

In-hospital outcomes of non-elective transapical transcatheter versus surgical aortic valve replacement. [PDF]

Sci Rep
Li R, Prastein DJ, Boyce SW, Choi BG.
europepmc   +1 more source

Companion Diagnostics in Clinical Therapy: Current Applications and Future Directions

MedComm, Volume 7, Issue 3, March 2026.
Companion diagnostics use biomarker‐based assays to stratify patients for precision therapies, improving outcomes while reducing ineffective treatment and side effects. This review summarizes the evolution, regulatory landscape, clinical applications, and technological platforms of CDx, highlighting their role in biomarker‐driven precision therapy.
Yuesong Wu, Rou Xue, Xiangwen Luo, Jiangnan Liao, Zongbo Zhang, Jinhai Deng, Teng Liu, Xin Li, Zhe‐Sheng Chen, Mingzhu Yin   +9 more
wiley   +1 more source

Feasibility of Valve in Valve After Transcatheter Aortic Valve Replacement With SAPIEN 3 Valves and Surgical Aortic Valve Replacement. [PDF]

Struct Heart
Sheth T, Al-Shamkani W, Makhdoum A, Viquez JC, Suleman M, Dick A, Sathananthan J, Wood D, Fam N, AlRaddadi H, Natarajan MK, Velianou JL.   +11 more
europepmc   +1 more source

Refining insights on type 2 diabetes and aortic valve replacement—reply to Liu et al.

Diabetic Medicine, Volume 43, Issue 4, April 2026.
Timothy M. E. Davis, Wendy A. Davis
wiley   +1 more source